Stilbènes : de la chimie à la neuroprotection

Renaud, 1992, Wine, alcohol, platelets, and the French paradox for coronary heart disease, Lancet, 339, 1523, 10.1016/0140-6736(92)91277-F Gronbaek, 1995, Mortality associated with moderate intakes of wine, beer, or spirits, BMJ, 310, 1165, 10.1136/bmj.310.6988.1165 Sun, 2002, The “French Paradox” and beyond: neuroprotective effects of polyphenols, Free Radic Biol Med, 32, 314, 10.1016/S0891-5849(01)00803-6 Fernández-Mar, 2012, Bioactive compounds in wine: resveratrol, hydroxytyrosol and melatonin: a review, Food Chem, 130, 797, 10.1016/j.foodchem.2011.08.023 Ramassamy, 2006, Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets, Eur J Pharmacol, 545, 51, 10.1016/j.ejphar.2006.06.025 Pawlus, 2012, Stilbenoid chemistry from wine and the genus Vitis, J Int Sci Vigne Vin, 46, 57 Bruneton, 2009 Pérez-Jiménez, 2010, A systematic analysis of the content of 502 polyphenols in 452 foods and beverages – An application of the Phenol-Explorer database, J Agric Food Chem, 58, 4959, 10.1021/jf100128b Quideau, 2001, Plant polyphenols: chemical properties. Biological activities and synthesis, Angew Chem Int Ed Engl, 50, 586, 10.1002/anie.201000044 Collin, 2011, 1 Rivière, 2012, Natural stilbenes: distribution in the plant kingdom and chemotaxonomic interest in vitaceae, Nat Prod Rep, 29, 1317, 10.1039/c2np20049j Stervbo, 2007, A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine, Food Chem, 101, 449, 10.1016/j.foodchem.2006.01.047 Jeandet, 2002, Phytoalexins from the vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity and metabolism, J Agric Food Chem, 50, 2731, 10.1021/jf011429s Vang, 2011, What is new for an old molecule? Systematic review and recommendations on the use of resveratrol, PLoS One, 6, e19881, 10.1371/journal.pone.0019881 Su, 2013, Comparision of piceid and resveratrol in antioxidation and antiproliferation activities in vitro, PLoS One, 8, e54505, 10.1371/journal.pone.0054505 Empl, 2012, The growth of the canine glioblastoma cell line D-GBM and the canine histiocytic sarcoma cell line DH82 is inhibited by the resveratrol oligomers hopeaphenol and r2-viniferin, Vet Comp Oncol, 10, 9999 Rivière, 2010, New stilbene dimers against amyloid fibril formation, Bioorg Med Chem Lett, 20, 3441, 10.1016/j.bmcl.2009.09.074 Soleas, 2001, Measurement of trans-resveratrol, (+)-catechin, and quercetin in rat and human blood and urine by gas chromatography with mass selective detection, Methods Enzymol, 335, 130, 10.1016/S0076-6879(01)35238-2 Soleas, 2001, Absorption of trans-resveratrol in rats, Methods Enzymol, 335, 145, 10.1016/S0076-6879(01)35239-4 Aumont, 2001, Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human, Arch Biochem Biophys, 393, 281, 10.1006/abbi.2001.2496 Vitrac, 2003, Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration, Life Sci, 72, 2219, 10.1016/S0024-3205(03)00096-1 Anekonda, 2006, Resveratrol-a boon for treating Alzheimer's disease?, Brain Res Rev, 52, 316, 10.1016/j.brainresrev.2006.04.004 Jin, 2008, Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats, Eur J Pharmacol, 600, 78, 10.1016/j.ejphar.2008.10.005 Gallez, 2005, 1 Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 Jang, 2003, Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death, Free Radic Biol Med, 34, 1100, 10.1016/S0891-5849(03)00062-5 Zhang, 2010, Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation, Eur J Pharmacol, 636, 1, 10.1016/j.ejphar.2010.03.043 Marambaud, 2005, Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides, J Biol Chem, 280, 37377, 10.1074/jbc.M508246200 Rivière, 2008, New polyphenols active on β-amyloid aggregation, Bioorg Med Chem Lett, 18, 828, 10.1016/j.bmcl.2007.11.028 Breuer, 2006, Blood-brain barrier permeability to the neuroprotectant oxyresveratrol, Neurosci Lett, 393, 113, 10.1016/j.neulet.2005.09.081 Ban, 2006, Neuroprotective effect of oxyresveratrol from Smilacis chinae rhizome on amyloid-β protein (25-35)-induced neurotoxicity in cultured rat cortical neurons, Biol Pharm Bull, 29, 2419, 10.1248/bpb.29.2419 Jeon, 2007, β-secretase (BACE1)-inhibiting stilbenoids from Smilax Rhizoma, Phytomedicine, 14, 403, 10.1016/j.phymed.2006.09.003 Chao, 2008, Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity, Free Radic Biol Med, 45, 1019, 10.1016/j.freeradbiomed.2008.07.002 Jin, 2006, Piceatannol attenuates lipopolysaccharide-induced NF-kB activation and NF-kB-related proinflammatory mediators in BV2 microglia, Pharmacol Res, 54, 461, 10.1016/j.phrs.2006.09.005 Kim, 2008, Piceatannol attenuates hydrogen-peroxide- and peroxynitrite-induced apoptosis of PC12 cells by blocking down-regulation of Bcl-XL and activation of JNK, J Nutr Biochem, 19, 459, 10.1016/j.jnutbio.2007.06.001 Chao, 2010, Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells, J Nutr Biochem, 21, 482, 10.1016/j.jnutbio.2009.02.004 Ruan, 2010, Protective effects of trans-2, 4-dimethoxystibene on cognitive, impairments induced by Aβ25-35 in hypercholesterolemic rats, Brain Res Bull, 82, 251, 10.1016/j.brainresbull.2010.04.016 Chang, 2012, Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease, Neurobiol Aging, 33, 2062, 10.1016/j.neurobiolaging.2011.08.015 Wang, 2009, Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kB pathways and inhibition of intracellular ROS/RNS generation, Free Radic Biol Med, 47, 229, 10.1016/j.freeradbiomed.2009.02.027 Luo, 2009, Tetrahydroxystilbene glucoside reduces the cognitive impairment and the overexpression of amyloid precursor protein induced by aluminium exposure, Neurosci Bull, 25, 391, 10.1007/s12264-009-0601-4 Li, 2010, Tetrahydroxystilbene glucoside attenuates MMP±induced apoptosis in PC12 cells by inhibiting ROS generation and modulating JNK activation, Neurosci Lett, 483, 1, 10.1016/j.neulet.2010.07.027 Wang, 2011, Tetrahydroxystilbene glucoside, a plant-derived cognitive enhancer, promotes hippocampal synaptic plasticity, Eur J Pharmacol, 650, 206, 10.1016/j.ejphar.2010.10.002 Rivière, 2007, Inhibitory activity of stilbenes on Alzheimer's β-amyloid fibrils in vitro, Bioorg Med Chem, 15, 1160, 10.1016/j.bmc.2006.09.069 Kim, 2012, Neuroprotection of the leaf and stem of Vitis amurensis and their active compounds against ischemic brain damage in rats and excitotoxicity in cultured neurons, Phytomedicine, 19, 150, 10.1016/j.phymed.2011.06.015 Nassra, 2013, Inhibitory activity of plant stilbenoids against nitric oxide production by lipopolysaccharide-activated microglia, Planta Med, 79, 966, 10.1055/s-0032-1328651 Jang, 2007, Resveratrol oligomers from Vitis amurensis attenuate β-amyloid-induced oxidative stress in PC12 cells, Biol Pharm Bull, 30, 1130, 10.1248/bpb.30.1130 Richard, 2011, Protective effect of ɛ-viniferin on β-amyloid peptide aggregation investigated by electrospray ionization mass spectrometry, Bioorg Med Chem, 19, 3152, 10.1016/j.bmc.2011.04.001 Lee, 2007, Neuroprotective effects of kobophenol A against the withdrawal of tropic support, nitrasative stress, and mitochondrial domage in SH-SY5Y neuroblastoma cells, Bioorg Med Chem Lett, 17, 1879, 10.1016/j.bmcl.2007.01.078 Richard, 2013, 3D NMR structure of a complex between the amyloid β peptide (1–40) and the polyphenol ɛ-viniferin glucoside: implications in Alzheimer's disease, Biochim Biophys Acta, 1830, 5068, 10.1016/j.bbagen.2013.06.031